Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eunhee Kim

Showing results (281-290 of 286) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 286 results.
Nature|July 15, 2021
Astrocytic interleukin-3 programs microglia and limits Alzheimer's diseaseCameron S McAlpine, Joseph Park, Ana Griciuc, et al.
The Journal of Experimental Medicine|November 13, 2013
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivoOmar Abdel-Wahab, Jie Gao, Mazhar Adli, et al.
Molecular Cell|July 7, 2015
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 SignalingHee-Bum Kang, Jun Fan, Ruiting Lin, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
Neurology|October 27, 2019
Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophiesMinal S Jain, Katherine Meilleur, Eunhee Kim, et al.
Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.
Pageof 29

Showing results (281-290 of 286) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 286 results.
Nature|July 15, 2021
Astrocytic interleukin-3 programs microglia and limits Alzheimer's diseaseCameron S McAlpine, Joseph Park, Ana Griciuc, et al.
The Journal of Experimental Medicine|November 13, 2013
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivoOmar Abdel-Wahab, Jie Gao, Mazhar Adli, et al.
Molecular Cell|July 7, 2015
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 SignalingHee-Bum Kang, Jun Fan, Ruiting Lin, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
Neurology|October 27, 2019
Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophiesMinal S Jain, Katherine Meilleur, Eunhee Kim, et al.
Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.
Pageof 29